LumaGEM MBI System uses technology developed by Mayo Clinic phycisians, scientists and technocians, licensed exclusively to CMR Naviscan. Current system uses a low dose of 240 - 300 MBq of 99Tc-Sestamibi for imaging. Ultra low dose imaging (when compared with current system) of 150 MBq or lower using Clear MBI image-processing algorithm (licensed from Photon Tech Solutions) is under development. [1]. Current MBI applications are: Supplemental Screening, Extent of Disease, Response to Neoadjuvent Chemotherapy, Problem Solving and Risk Assesment. [2]
CZT Dual Detectors, Registered Tugsten Collimators. Application Sofware includin static/dinamic acquisition and processing modes. Dicom 3.1, Windows 10 OS
References: [1] Tao et al, AJR 214-Jan 2020 [2] K. Hunt, SBIJ 416-426 Jul 2021